Suspended
A Proof of Concept Top Evaluate a Novel Penile Lengthening Protocol
What is being collected
Data Collection
Collected from today forward - ProspectiveWho is being recruted
From 20 to 55 Years
+21 Eligibility Criteria
How is the trial designed
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Observational
Study Start: November 2019
Summary
Principal SponsorJudson Brandeis
Study ContactJudson Brandeis, MD
Last updated: January 28, 2026Sourced from a government-validated database.Claim as a partner
Study start date: November 12, 2019
Actual date on which the first participant was enrolled.The objective of this study is to examine and quantify the efficacy and safety of a new treatment protocol using platelet-rich plasma for penile length enhancement.
Official TitleA Proof of Concept Top Evaluate a Novel Penile Lengthening Protocol
Principal SponsorJudson Brandeis
Study ContactJudson Brandeis, MD
Last updated: January 28, 2026Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
30 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Criteria
Male
Biological sex of participants that are eligible to enroll.From 20 to 55 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
7 inclusion criteria required to participate
Stretched penile length between 3.5 - 8.0 in
Age 20-55 years of age
Desire penile length elongation
Willing to complete all aspects of combined treatment plan
Show More Criteria
14 exclusion criteria prevent from participating
Testosterone level lower than 500
No prior surgical Peyronie's disease treatment
No chordee with or without hypospadias
No infiltration by benign or malignant mass
Show More Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Recruiting
SuspendedOne Study Center